Cite
APA Citation
Zakharia, Y., Drabick, J., Khleif, S., Munn, D., Link, C., Vahanian, N., Kennedy, E., Rixe, O., & Milhem, M. (n.d.). 514 Results of Phase 1b trial of the Indoleamine 2, 3-dioxygenase (IDO) Pathway Inhibitor Indoximod plus Ipilimumab for the treatment of unresectable stage III or IV melanoma. European journal of cancer, 51, S108–. http://access.bl.uk/ark:/81055/vdc_100030628048.0x00002b